This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)
C3_RECTUM_MUCINO_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
149 |
4. Check minimum number of eventsNone |
149 |
5. Include endpointsNone |
149 |
6. Filter based on genotype QC (FinnGen only) |
149 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Mucinous and mucinous cystic tumor of rectum
- Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum
- Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)
- Colorectal cancer
- Colorectal cancer, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 149 | 49 | 100 |
| Unadjusted period prevalence (%) | 0.04 | 0.02 | 0.04 |
| Median age at first event (years) | 68.42 | 67.31 | 68.96 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 137
- Matched controls
- 1368
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
157.2
119
*
8480/3-C20.9
ICD-O-3
Mucinous adenocarcinoma of rectum, NOS
+∞
146.3
113
*
130
Kela drug reimbursment
Malignant tumour
+∞
121.7
98
*
L01BC06
ATC
capecitabine; oral
+∞
95.2
80
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
80.3
69
*
A03FA01
ATC
metoclopramide; systemic, rectal
37.0
64.2
88
63
H02AB02
ATC
dexamethasone; systemic
160.3
50.9
51
5
A04AA02
ATC
granisetron; systemic, transdermal
+∞
48.9
44
*
JN4BD
NOMESCO Finland
Extensive body CT
41.6
47.9
60
25
UJF32
NOMESCO Finland
Coloscopy
15.1
44.2
104
236
WX302
NOMESCO Finland
Thoracal epidural anesthesy
78.4
42.9
47
9
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
41.8
38
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
41.8
38
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
20.7
40.9
65
57
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
489.8
38.0
36
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
29.2
27
*
JFF23
NOMESCO Finland
Transversostomy
+∞
28.1
26
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
27.0
25
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
27.0
25
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
27.0
25
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
8.1
26.6
75
177
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
+∞
25.8
24
*
8480/3-C19.9
ICD-O-3
Mucinous adenocarcinoma of rectosigmoid junction
+∞
25.8
24
*
WZC30
NOMESCO Finland
Teaching
12.8
25.8
49
57
B01AB05
ATC
enoxaparin; parenteral
7.4
25.7
83
235
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
24.7
23
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
288.3
24.5
24
*
WX408
NOMESCO Finland
General anesthesy, balanced
7.2
23.8
73
187
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
23.6
22
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
23.6
22
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
+∞
23.6
22
*
JG1BG
NOMESCO Finland
MRI of rectum
+∞
23.6
22
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
75.7
22.7
25
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
22.5
21
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
19.2
22.2
34
23
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
41.5
22.1
27
8
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
+∞
21.4
20
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
21.4
20
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
21.4
20
*
XX3DW
NOMESCO Finland
Time consuming IT work
14.7
19.9
34
30
JN4AD
NOMESCO Finland
Body CT examination
19.0
19.0
29
19
B01AB10
ATC
tinzaparin; parenteral
16.3
18.5
30
23
D75
ICPC
Malignant neoplasm colon/rectum
+∞
17.0
16
*
TPH07
NOMESCO Finland
Cathetrisation of artery
7.6
16.0
40
70
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
+∞
15.9
15
*
JG1CG
NOMESCO Finland
Extensive MRI of rectum
+∞
15.9
15
*
ZXE20
NOMESCO Finland
More than three and less than five hours
6.8
15.3
42
84
TJF80
NOMESCO Finland
Ostomy education
64.1
15.2
17
*
ZXC96
NOMESCO Finland
Robot assisted procedure
+∞
14.9
14
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
14.9
14
*
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
167.1
14.8
15
*
N02AA05
ATC
oxycodone; systemic
7.0
14.7
39
74
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
+∞
13.8
13
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.8
13
*
JN4CD
NOMESCO Finland
Very extensive body CT
19.3
13.5
20
12
Z51.5
ICD-10 Finland
Palliative care
19.3
13.5
20
12
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
12.3
12.8
23
22
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
77.2
12.8
14
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
12.7
12
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
12.7
12
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
6.6
12.0
32
60
SPAT1125
SPAT
Stoma care and guidance
25.6
11.9
16
7
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
11.6
11
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
+∞
11.6
11
*
Z93.3
ICD-10 Finland
Colostomy status
130.5
11.6
12
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.0
10.9
23
30
ZX120
NOMESCO Finland
Intravenous
7.6
10.6
25
39
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
118.7
10.6
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
10.5
10
*
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
+∞
10.5
10
*
WF002
NOMESCO Finland
Radical radiotherapy
59.3
9.8
11
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
11.9
9.6
17
16
WF003
NOMESCO Finland
Adjuvant radiotherapy
107.1
9.5
10
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
107.1
9.5
10
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
9.5
9
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
9.5
9
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
9.5
9
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
9.5
9
*
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
+∞
9.5
9
*
JGB31
NOMESCO Finland
Laparoscopic and perineal excision of rectum
+∞
9.5
9
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.5
9
*
JFF10
NOMESCO Finland
Loop enterostomy
+∞
9.5
9
*
A04AA01
ATC
ondansetron; systemic, rectal
15.4
8.9
14
10
JFB00
NOMESCO Finland
Partial resection of small intestine
29.6
8.6
11
*
SPAT1262
SPAT
Handing over of treatment supplies
3.6
8.5
44
160
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
35.7
8.2
10
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.9
7.9
26
63
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
12.9
7.8
13
11
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
10.2
7.5
14
15
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
7.3
7.4
17
26
JAH01
NOMESCO Finland
Laparoscopy
16.9
7.4
11
7
JGB36
NOMESCO Finland
Wide excision of rectum
+∞
7.4
7
*
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
+∞
7.4
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.4
7
*
WW500
NOMESCO Finland
Blood transfusion
9.0
7.0
14
17
D18
ICPC
Change in faeces/bowel movements
11.8
6.9
12
11
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
6.1
6.9
18
33
WX600
NOMESCO Finland
Single shot through catheter
42.2
6.8
8
*
K56.7
ICD-10 Finland
Ileus, unspecified
15.3
6.5
10
7
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
15.3
6.5
10
7
Z93
ICD-10 Finland
Artificial opening status
73.1
6.5
7
*
ZZR00
NOMESCO Finland
Flap of skin
73.1
6.5
7
*
JAH00
NOMESCO Finland
Laparotomy
10.0
6.4
12
13
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.9
6.4
20
46
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
6.3
6
*
JGB01
NOMESCO Finland
Laparoscopic partial proctectomy and colorectal or coloanal anastomosis
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
6.3
6
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
6.3
6
*
L01XE21
ATC
[U] regorafenib; oral
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
L01BC59
ATC
trifluridine, combinations; systemic
+∞
6.3
6
*
JGB37
NOMESCO Finland
Laparoscopic wide excision of rectum
+∞
6.3
6
*
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
6.2
40
166
LCD00
NOMESCO Finland
Hysterectomy
13.4
6.2
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
121
66
93.24
171.44
11.9
1.4
ug/l
14.5
7.1
0.60
112
51
(3022145) Colonoscopy Study observation
61
110
8.70
35.87
1.6
1.3
—
—
—
0
0
(4035726)
33
42
9.81
25.34
1.7
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
104
482
4.83
18.66
7.5
3.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
32
67
5.81
15.31
1.9
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
75
322
3.68
13.88
5.8
3.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
97
501
3.68
13.26
16.0
10.1
inr
1.3
1.4
0.50
26
125
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
40
116
4.35
12.91
3.6
2.5
umol/l
9.3
7.8
0.21
32
102
(3013650) Neutrophils [#/volume] in Blood by Automated count
108
616
3.74
12.26
23.1
6.0
e9/l
3.8
4.5
2.26
98
537
(3044640) Blood type and Crossmatch panel - Blood
72
330
3.29
11.53
3.4
2.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
72
336
3.21
11.09
2.7
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
45
168
3.40
9.87
3.7
2.6
mmol/l
0.8
0.8
1.53
45
159
(3026008) Bacteria identified in Urine by Culture
68
324
3.02
9.86
3.9
3.1
—
—
—
0
0
(3002256) Pathology report gross observation
28
77
4.25
9.53
1.3
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
55
254
2.85
8.18
2.9
2.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
40
4.98
7.89
1.9
1.9
u/ml
0.2
0.4
1.34
11
19
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
91
558
2.62
7.50
8.1
5.9
mmol/l
1.2
1.2
1.87
72
479
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
26
5.84
7.40
1.6
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
36
144
2.98
6.84
11.2
7.0
mmol/l
1.7
1.3
0.25
29
116
(3019060) Gas panel - Arterial blood
26
87
3.41
6.62
8.5
4.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
51
259
2.47
6.01
1.4
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
36
155
2.74
5.92
3.5
5.1
mmol/l
1.0
1.0
0.32
36
142
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
61
3.63
5.82
13.9
9.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
17
50
3.71
5.20
2.1
1.6
ug/l
1.0
1.5
0.28
17
42
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
26
102
2.88
5.04
2.7
1.9
u/l
27.2
32.5
0.78
26
81
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
79
515
2.14
4.92
7.9
5.4
mmol/l
1.2
1.2
1.49
70
456
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
24
4.87
4.87
1.9
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
100
730
2.12
4.44
6.5
3.9
e6/l
794.4
3178.8
—
5
11
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
37
184
2.34
4.44
1.8
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
36
178
2.35
4.37
3.1
1.7
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
12
31
4.12
4.35
2.0
2.6
g/l
3.3
4.2
0.83
12
31
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
114
2.55
4.06
3.5
3.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
12
6.97
3.72
1.4
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
12
6.97
3.72
1.4
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
12
6.97
3.72
1.4
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
12
6.97
3.72
1.4
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
12
6.97
3.72
1.4
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
12
6.97
3.72
1.4
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
47
279
2.00
3.55
5.9
3.3
%
76.7
84.6
0.98
47
272
(3002030) Lymphocytes/100 leukocytes in Blood
75
522
1.88
3.52
6.0
5.3
%
21.0
26.3
3.60
68
476
(3000850) Epithelial cells [#/volume] in Urine
42
243
2.01
3.39
3.0
2.1
e6/l
11.9
3.8
0.61
35
205
(3018010) Neutrophils/100 leukocytes in Blood
74
520
1.84
3.31
6.1
5.1
%
63.6
58.4
2.64
68
478
(3022096) Basophils/100 leukocytes in Blood
71
499
1.81
3.12
5.6
5.2
%
0.5
0.7
2.03
64
453
(3037467) Urinalysis macro (dipstick) panel - Urine
101
790
1.86
3.11
7.0
4.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
7
12
6.06
3.05
1.6
1.4
pmol/l
85.8
62.6
—
7
12
(3006504) Eosinophils/100 leukocytes in Blood
72
512
1.79
3.02
5.8
5.2
%
2.3
2.9
1.81
66
468
(3019069) Monocytes/100 leukocytes in Blood
72
516
1.77
2.91
5.9
5.5
%
9.2
8.8
0.32
66
475
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
18
80
2.42
2.73
2.8
3.1
mmol/l
1.2
1.2
0.08
13
70
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
101
1177
0.56
2.63
4.8
5.0
mmol/l
1.3
1.4
1.77
96
1060
(3002582) Erythrocytes [#/volume] in Urine
53
356
1.76
2.63
3.5
2.8
e6/l
16.7
250.2
0.68
44
270
(3006184) Hemoglobin [Mass/volume] in Capillary blood
9
25
3.76
2.62
2.2
1.8
g/l
109.0
124.9
—
9
16
(3007853) Bacteria identified in Skin by Aerobe culture
26
138
2.07
2.62
1.6
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
73
541
1.68
2.51
6.3
5.1
estimate
0.0
0.0
0.00
15
94
(3019198) Lymphocytes [#/volume] in Blood
76
570
1.68
2.50
5.4
5.0
e9/l
1.4
1.8
4.93
67
492
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
106
1212
0.57
2.41
5.1
5.6
mmol/l
2.7
2.6
0.34
95
1092
(3018418) pH of Serum or Plasma
48
321
1.73
2.39
4.1
3.5
ph
7.4
7.4
0.23
12
52
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
103
1185
0.58
2.35
4.8
5.0
mmol/l
4.5
4.4
0.19
97
1072
(3041096) Erythrocytes [Presence] in Urine by Automated
45
299
1.72
2.28
5.2
3.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
72
542
1.64
2.27
5.0
3.7
estimate
0.0
0.0
0.00
15
93
(3013115) Eosinophils [#/volume] in Blood
76
582
1.62
2.22
5.8
5.0
e9/l
0.1
0.2
5.02
67
502
(3023183) Ammonium ion [Moles/volume] in Plasma
9
31
3.02
2.11
2.4
1.8
umol/l
37.7
27.7
—
9
26
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
59
429
1.62
2.10
3.6
2.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
72
550
1.60
2.09
5.0
3.7
estimate
0.0
0.0
0.00
13
87
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
50
2.52
2.08
1.2
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
38
247
1.72
2.07
20.6
4.4
—
—
—
0
0
(3026782) Osmolality of Urine
37
239
1.73
2.06
2.5
2.6
mosm/kgh2o
514.5
568.6
0.82
29
195
(3021901) Oxygen saturation in Capillary blood
7
21
3.44
1.99
3.0
2.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
19
100
2.03
1.96
9.3
8.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
11
4.66
1.95
1.4
1.5
u/ml
4.0
339.2
—
5
11
(3006315) Basophils [#/volume] in Blood
73
566
1.57
1.95
5.3
4.9
e9/l
0.0
0.0
2.02
62
481
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
22
124
1.91
1.88
2.1
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
72
560
1.55
1.88
5.0
4.9
e9/l
0.6
0.6
0.14
63
473
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
58
430
1.57
1.87
5.7
3.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
66
505
1.55
1.85
16.8
8.5
e9/l
0.0
0.0
0.69
57
409
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
22
125
1.89
1.84
2.1
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
44
308
1.61
1.79
3.1
2.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
24
3.01
1.74
1.3
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
32
208
1.69
1.73
2.0
1.7
s
30.9
29.7
0.37
32
198
(3028626) Oxygen [Partial pressure] in Capillary blood
8
31
2.67
1.68
4.5
2.2
kpa
7.9
7.8
—
8
25
(3018095) Leukocytes [#/volume] in Urine
55
414
1.52
1.62
3.9
3.2
e6/l
45.6
66.6
0.35
46
290
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
38
263
1.60
1.61
3.8
3.8
ng/l
544.5
156.7
0.37
27
223
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
13
64
2.13
1.59
12.8
8.9
mmol/l
24.8
24.8
0.01
13
57
(3022621) pH of Urine by Test strip
13
64
2.13
1.59
3.7
2.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
25
156
1.72
1.56
1.6
2.5
%
19.2
24.2
1.03
20
143
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
72
2.04
1.54
2.1
2.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
45
2.31
1.50
1.1
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
11
52
2.20
1.48
1.3
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
16
90
1.87
1.39
4.3
3.4
—
—
—
0
0
(3012544) pH of Venous blood
22
137
1.71
1.39
2.5
3.9
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
13
68
2.00
1.38
2.9
3.5
mmol/l
24.7
24.6
0.04
13
68
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
23
2.67
1.38
1.3
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
71
843
0.70
1.35
3.5
3.6
pmol/l
14.8
15.2
0.72
62
734
(3020961) Endomysium IgA Ab [Titer] in Serum
9
43
2.16
1.33
1.1
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
49
375
1.46
1.29
5.2
5.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
18
2.84
1.29
1.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
170
0.50
1.28
33.1
7.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
40
296
1.48
1.25
6.4
3.7
estimate
0.0
0.0
0.00
12
89
(40768797) Stomach Pathology biopsy report
8
154
0.49
1.22
1.4
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
32
228
1.51
1.19
4.0
4.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
33
0.00
1.17
0.0
1.2
—
2.2
—
0
6
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
33
0.00
1.17
0.0
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
97
1077
0.72
1.10
4.4
4.4
mu/l
2.1
2.0
0.41
89
941
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
124
1141
1.52
1.09
37.4
13.4
mg/l
42.1
24.3
5.15
118
880
(3013512) EKG study
51
406
1.39
1.06
3.9
4.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
20
131
1.61
1.06
2.5
3.8
mmol/l
1.4
2.0
0.29
14
101
(3015736) pH of Urine
53
427
1.37
1.03
5.0
3.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
35
2.05
1.01
1.6
1.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
7
36
1.99
0.98
2.4
3.9
mmol/l
1.9
1.5
—
7
36
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
0
32
0.00
0.96
0.0
1.2
—
2.2
—
0
5
(3030467) Casts [#/volume] in Urine by Automated count
42
333
1.36
0.89
3.4
2.7
e6/l
0.5
0.4
0.12
31
239
(3003327) Ova and parasites identified in Stool by Light microscopy
6
30
2.04
0.88
1.2
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
31
1.97
0.85
5.5
4.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
11
65
1.75
0.85
4.3
2.8
e6/l
1.5
0.2
0.88
11
65
(3004119) Hemoglobin [Mass/volume] in Venous blood
14
89
1.63
0.84
2.4
3.5
g/l
123.1
127.5
0.39
14
89
(3017181) Myelocytes/100 leukocytes in Blood
13
83
1.62
0.78
6.5
4.6
%
1.9
1.0
—
5
22
(3020891) Body temperature
9
54
1.71
0.76
10.0
3.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
26
1.95
0.71
1.6
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
5
92
0.53
0.69
1.2
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
44
1.62
0.66
3.7
5.1
—
—
—
0
0
(3044889) 12 lead EKG panel
94
861
1.25
0.61
4.7
4.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
23
0.00
0.59
0.0
1.3
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
6
35
1.74
0.58
2.5
4.0
mmol/l
9.1
7.8
—
6
35
(3000330) Specific gravity of Urine by Test strip
10
65
1.58
0.57
3.1
4.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
38
1.60
0.55
1.3
3.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
12
83
1.48
0.53
4.1
4.3
kpa
4.9
5.1
0.46
12
73
(3019225) pH of Specimen
16
118
1.40
0.53
2.2
3.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
47
1.51
0.48
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
51
1.39
0.44
1.0
1.3
—
—
—
0
0
(4010399)
6
91
0.65
0.44
1.0
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
42
478
0.83
0.42
3.6
4.1
mg/mmol
5.4
8.8
0.61
29
288
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
7
104
0.66
0.41
1.1
1.6
g/l
64.5
67.2
—
7
93
(3012516) Albumin [Mass/volume] in Urine
39
445
0.83
0.40
2.9
3.3
mg/l
51.1
210.6
0.57
30
287
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
35
1.44
0.39
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
35
1.44
0.39
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
35
1.44
0.39
2.0
1.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
19
0.00
0.39
0.0
1.1
—
7.8
—
0
7
(42529406) Shigella sp [Presence] in Stool by Culture
5
36
1.40
0.38
1.0
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
59
535
1.17
0.38
3.9
4.0
ng/l
21.0
103.8
0.78
42
404
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
73
1.40
0.35
1.6
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
12
91
1.35
0.35
1.0
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
29
251
1.19
0.31
1.8
1.7
nmol/l
994.7
1206.6
0.75
24
184
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
58
533
1.14
0.30
2.1
2.0
pmol/l
81.7
94.3
1.12
40
263
(40761535) Cells panel - Urine sediment
8
109
0.72
0.30
4.3
2.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
25
215
1.20
0.29
1.0
1.3
u/ml
1.9
1.4
—
6
60
(3019150) Specific gravity of Urine by Refractometry
28
244
1.18
0.28
7.8
3.9
kg/l
1.0
1.0
—
6
36
(3000494) Fungus identified in Specimen by Culture
17
141
1.23
0.27
3.0
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
136
0.79
0.24
1.3
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
13
106
1.25
0.24
1.2
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
40
1.26
0.22
3.0
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
22
192
1.17
0.22
1.1
1.3
g/l
2.5
3.0
0.74
15
106
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4062490)
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
188.7
—
0
7
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
115
1117
1.13
0.21
33.8
12.5
ml/min/173m2
79.6
74.6
2.21
102
887
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
47
504
0.90
0.20
3.9
3.7
%
19.6
24.5
1.45
22
244
(3017143) Hepatitis C virus Ab [Presence] in Serum
11
91
1.23
0.18
1.0
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
60
1.17
0.18
1.9
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
32
349
0.89
0.18
2.3
2.7
ug/l
0.7
0.7
0.00
21
244
(3022313) Gas panel - Capillary blood
7
62
1.14
0.17
4.6
4.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
23
206
1.14
0.17
15.9
23.3
inr
1.4
1.2
—
7
26
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
5
70
0.70
0.17
1.0
1.4
—
27.3
—
0
7
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
79
1.15
0.15
1.6
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
85
0.81
0.15
1.7
1.3
—
—
—
0
0
(3000492) Spirometry study
12
104
1.17
0.13
1.4
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
22
201
1.11
0.12
3.2
2.4
e6/l
0.4
1.3
1.69
14
109
(3020564) Creatinine [Moles/volume] in Serum or Plasma
126
1240
1.10
0.12
46.7
15.9
umol/l
79.0
84.7
1.63
126
1240
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
47
448
1.07
0.11
2.7
2.9
ng/l
1699.3
1402.5
0.27
41
374
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
43
1.17
0.10
1.0
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
45
1.11
0.10
1.2
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
36
377
0.94
0.08
3.8
3.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
7
67
1.05
0.08
2.3
2.7
%
0.8
1.2
—
7
67
(36660697) Celiac disease serology panel - Serum
7
67
1.05
0.08
1.1
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
20
188
1.07
0.06
3.4
2.7
e6/l
0.3
2.5
2.07
12
97
(3009542) Hematocrit [Volume Fraction] of Blood
100
1010
0.97
0.03
37.7
14.6
%
36.9
40.1
1.74
58
648
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
16
168
0.95
0.02
1.3
1.3
u/ml
0.9
12.0
—
8
57
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
43
439
0.97
0.02
2.1
2.2
nmol/l
68.1
78.0
1.44
37
371
(40761511) CBC panel - Blood by Automated count
121
1203
1.03
0.01
38.3
12.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
25
254
0.98
0.00
4.9
3.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
103
0.97
0.00
1.1
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
54
539
1.00
0.00
2.2
2.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3000012) Reticulocyte production index
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
0.3
—
0
5
(44806420)
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
64
640
1.00
0.00
3.6
3.9
ug/l
2.6
2.1
0.66
53
562
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
84
0.95
0.00
1.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
13.8
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
5
53
0.94
0.00
5.4
3.3
pmol/l
4.6
4.4
—
5
48
(4015189)
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.2
—
10.0
—
0
6
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
6
62
0.97
0.00
3.7
1.8
ug/l
493.8
330.3
—
6
57
(21491868) Cryoglobulin [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
8.3
—
0
5
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
6
68
0.88
0.00
1.8
3.9
mmol/l
23.8
24.6
—
6
59
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
16.1
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RECTUM_MUCINO_EXALLC – Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).